Back to Repertoire

Acquired Cataract

Lens Opacity — Nuclear / Cortical / PSC

Lens — min read

Presentation

  • Progressive, painless blurring of vision.
  • Nuclear sclerotic: gradual myopic shift ("second sight"), possible monocular diplopia, colours appear more yellow/brown.
  • Cortical: glare and reduced contrast sensitivity, may be minimally symptomatic if opacities remain peripheral (spoke-like).
  • Posterior subcapsular (PSC): glare and haloes, disproportionately symptomatic for its size because of its central location; worse in bright light/miosis (night driving, reading in bright sun); tends to occur in younger patients.

Findings

★ Signature Finding

Type-specific slit-lamp appearance: Nuclear sclerosis — central yellow-to-brown opalescence; Cortical — peripheral wedge-shaped ("spoke") opacities on retroillumination; PSC — plaque-like opacity just beneath the posterior capsule, central, best seen on retroillumination.

  • Patients often have overlapping opacities in more than one zone.

Etiology & Mechanism

  • Age-related (senile) cataract — the most common type — is multifactorial: compaction/stiffening of central lens fibres as new cortical layers accumulate, plus oxidative damage and crystallin protein aggregation.
  • Diabetes mellitus — accelerated cortical/PSC change via osmotic lens fibre swelling (sorbitol pathway).
  • Corticosteroid use (topical, systemic, or inhaled) — classic cause of PSC cataract.
  • Blunt or penetrating trauma — can produce rosette/stellate cataract.
  • Chronic uveitis and/or its steroid treatment.
  • Ionizing radiation exposure — classically produces a PSC pattern.
  • High (pathologic) myopia — accelerated nuclear sclerosis.
  • Smoking and UV exposure — recognized environmental risk factors.

Red Flags — Do Not Miss

Critical — Do Not Miss
  • Unilateral, rapidly progressive cataract in a young patient — consider trauma, chronic intraocular inflammation, or an intraocular tumor-related (masquerade) process.
  • Cataract with a red or painful eye, or with iris neovascularisation — consider phacolytic or phacomorphic glaucoma, lens-induced uveitis, or intraocular malignancy.
  • A white/mature (hypermature) cataract — risk of phacomorphic angle closure or phacolytic glaucoma; needs prompt surgical planning rather than routine elective scheduling.

Investigations

  • Comprehensive slit-lamp exam and dilated fundus exam to detect coexisting posterior-segment pathology.
  • B-scan ultrasound if the fundus cannot be visualised, to exclude retinal detachment or intraocular mass before surgery.
  • Ocular biometry (optical or ultrasound) for intraocular lens power calculation.
  • Potential acuity/glare testing to correlate degree of visual complaint with cataract severity.
  • Specular microscopy if coexisting endothelial disease (e.g., Fuchs dystrophy) is suspected preoperatively.

Management

  • Non-surgical measures for early/mild disease: updated refraction, brighter task lighting, anti-glare strategies.
  • Surgical timing is generally guided by the degree of functional visual impairment and the patient's needs rather than a fixed visual-acuity cutoff.

Treatment

  • Definitive treatment is surgical: phacoemulsification with intraocular lens implantation is the standard of care in most settings.
  • Manual small-incision cataract surgery or extracapsular extraction may be used for very dense/mature cataracts or in resource-limited settings.
  • No medical or topical therapy is proven to reverse cataract.

Follow-up

  • Preoperative interval monitoring based on symptoms.
  • Standard postoperative visits (commonly day 1, week 1, and around month 1) to monitor for endophthalmitis, IOP spikes, and cystoid macular oedema.
  • Long-term monitoring for posterior capsular opacification ("secondary cataract"), treatable with Nd:YAG laser capsulotomy when visually significant.

Clinical Pearl

💡 Clinical Pearl

A cataract that develops rapidly and asymmetrically — especially with a shallow anterior chamber or elevated intraocular pressure — should raise suspicion for lens-induced (phacomorphic or phacolytic) glaucoma and prompt urgent rather than routine surgical referral.

Differential Diagnoses

ConditionKey Distinguishing Point
Age-related macular degenerationMetamorphopsia/central scotoma with macular findings on exam; can coexist with and be masked by cataract.
Fuchs endothelial corneal dystrophyCorneal guttae on exam, vision characteristically worse in the morning.
Primary open-angle glaucomaOptic nerve/visual field changes with a clear lens exam.
Diabetic retinopathyFundus findings (microaneurysms, haemorrhages) rather than lens opacity.
Posterior capsular opacificationHistory of prior cataract surgery; resolves with YAG laser capsulotomy.

References